Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03285516 · ClinicalTrials.gov registry record · NA
Safety Aid Reduction Treatment for Rural Veterans
A NA study, sponsored by Southeast Louisiana Veterans Health Care System.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT03285516: Completed NA study, sponsored by Southeast Louisiana Veterans Health Care System.
NCT03285516 is a NA study that has completed, run by Southeast Louisiana Veterans Health Care System. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03285516, a NA study, has completed, sponsored by Southeast Louisiana Veterans Health Care System.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The primary aim of the current proposal is to test the acceptability and feasibility of a group-based transdiagnostic treatment, termed Safety Aid Reduction Treatment (START), delivered to rural Veterans. The anticipated results of the proposed study include: 1) START will be both acceptable and feasible to Veterans and mental health care providers, alike and 2) START will lead to meaningful reductions in symptoms of anxiety and depression.
Primary Outcome
The START Qualitative Treatment Questionnaire is a brief, structured short-answer qualitative questionnaire that was developed by the research team to assess Veterans experience with the START protocol.
Interventions
- BEHAVIORAL Safety Aid Reduction Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2018-04-16 |
| Est. Completion | 2019-04-30 |
| Phase | NA |
What the finished NCT03285516 record still lists
NCT03285516 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Safety Aid Reduction Treatment is the first listed.
NCT03285516 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03285516 about?
NCT03285516 is a clinical study titled "Safety Aid Reduction Treatment for Rural Veterans". The primary aim of the current proposal is to test the acceptability and feasibility of a group-based transdiagnostic treatment, termed Safety Aid Reduction Treatment (START), delivered to rural Veterans. The anticipated results of the proposed study include: 1) START will be both acceptable and fea...
What is the current status of trial NCT03285516?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2018-04-16. Estimated completion is 2019-04-30.
What interventions are being tested in trial NCT03285516?
The interventions under investigation include: Safety Aid Reduction Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT03285516?
This trial is sponsored by Southeast Louisiana Veterans Health Care System, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03285516's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI